Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.90
0.54%
Copper
4.13
(0.46%)
Oil
70.27
1.78%
Bitcoin
97,605.08
3.45%
FTSE 100
8,119.53
0.43%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.27%
Hang Seng
19,601.11
(0.23%)

TELIX Pharmaceuticals Ltd

TLX

ASX

Telix Pharmaceuticals Limited (TLX) is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. Telix is developing a portfolio of clinical stage products that aims to address unmet medical needs in oncology and rare diseases.

Latest Posts

Line Chart with Gradient
Price
$22.200
-0.76 (-3.31%)
At Close 20/11 (AEST)
Related Companies
STARPHARMA HOLDINGS LIMITED
$SPL
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
$MVP
ANATARA LIFESCIENCES LTD
$ANR
IMUGENE LIMITED
$IMU
NYRADA INC.
$NYR

Leave a Comment on TLX


Comments for TLX

    Latest Posts

    telix-pharmaceuticals-asx-tlx-expands-theranostic-pipeline-with-new-fap-assets-tlx
    Health Care $TLX
    Telix Pharmaceuticals (ASX: $TLX) expands theranostic pipeline with new FAP assetsFocuses on bladder cancer, enhancing urology portfolio alongside kidney and prostate cancer programs
    November 19, 2024
    telix-pharmaceuticals-asx-tlx-expands-theranostic-pipeline-with-new-fap-targeting-assets-tlx
    Health Care $TLX
    Telix Pharmaceuticals (ASX: $TLX) expands theranostic pipeline with new FAP-targeting assetsTelix strengthens urology portfolio, targeting bladder cancer with strategic acquisition of FAP assets
    November 19, 2024
    telix-pharmaceuticals-asx-tlx-announces-cms-policy-change-for-radiopharmaceutical-reimbursement-tlx
    Health Care $TLX
    Telix Pharmaceuticals (ASX: $TLX) announces CMS policy change for radiopharmaceutical reimbursementCenters for Medicare & Medicaid Services to ensure consistent reimbursement starting 2025, enhancing patient access
    November 4, 2024
    telix-pharmaceuticals-asx-tlx-advances-tlx101-cdx-for-glioma-imaging-tlx
    Health Care $TLX
    Telix Pharmaceuticals (ASX: $TLX) advances TLX101-CDx for glioma imagingFDA accepts NDA for Pixclara, priority review with potential U.S. launch by 2025
    October 24, 2024
    telix-asx-tlx-to-acquire-rls-to-expand-north-american-manufacturing-and-distribution-platform-tlx
    Health Care $TLX

    Telix (ASX: $TLX) to acquire RLS to expand North American manufacturing and distribution platform

    Acquisition of RLS to strengthen Telix's North American radiopharmaceutical network

    September 23, 2024

    telix-asx-tlx-elects-to-withdraw-from-proposed-u-s-listing-tlx
    Health Care $TLX

    Telix (ASX: $TLX) elects to withdraw from proposed U.S. listing

    Company decides not to move forward with IPO in the United States

    June 14, 2024

    telix-asx-tlx-files-registration-statement-for-proposed-initial-public-offering-tlx
    Health Care $TLX

    Telix (ASX: $TLX) files registration statement for proposed initial public offering

    Proposes offering of American Depository Shares in the U.S. with Jefferies, Morgan Stanley, Truist Securities, and William Blair as joint book-running managers

    May 20, 2024

    telix-asx-tlx-completes-acquisition-of-isotherapeutics-tlx
    Health Care $TLX

    Telix (ASX: $TLX) completes acquisition of IsoTherapeutics

    Strengthens in-house development capabilities and expands U.S. manufacturing footprint

    April 9, 2024

    telix-asx-tlx-addresses-shareholders-at-general-meeting-tlx
    Health Care $TLX

    Telix (ASX: $TLX) addresses shareholders at general meeting

    Chairman and CEO discuss growth strategy, acquisitions, and potential Nasdaq listing

    April 5, 2024

    telix-asx-tlx-outlines-vision-for-global-theranostics-leadership-tlx
    Health Care $TLX

    Telix (ASX: $TLX) outlines vision for global theranostics leadership

    Plans for Phase III prostate cancer trial and expansion of commercial portfolio

    April 5, 2024

    telix-asx-tlx-acquires-artms-inc-to-enhance-radioisotope-production-tlx
    Health Care $TLX

    Telix (ASX: $TLX) acquires ARTMS Inc. to enhance radioisotope production

    Acquisition to boost production capacity and support commercial products

    March 5, 2024

    telix-asx-tlx-to-acquire-advanced-isotope-production-platform-tlx
    Health Care $TLX

    Telix (ASX: $TLX) to acquire advanced isotope production platform

    Acquisition of ARTMS, Inc. to enhance Telix's supply chain and manufacturing capabilities

    March 5, 2024

    telix-asx-tlx-expands-u-s-development-and-manufacturing-infrastructure-with-acquisition-of-isotherapeutics-tlx
    Health Care $TLX

    Telix (ASX: $TLX) expands u.s. development and manufacturing infrastructure with acquisition of IsoTherapeutics

    Acquires specialty radiopharmaceutical development and bioconjugation firm in Texas

    February 27, 2024

    TLX

    $TLX

    Telix Pharmaceuticals (ASX: $TLX) expands theranostic pipeline with new FAP assets

    Focuses on bladder cancer, enhancing urology portfolio alongside kidney and prostate cancer programs

    TLX

    $TLX

    Telix Pharmaceuticals (ASX: $TLX) expands theranostic pipeline with new FAP-targeting assets

    Telix strengthens urology portfolio, targeting bladder cancer with strategic acquisition of FAP assets

    TLX

    $TLX

    Telix Pharmaceuticals (ASX: $TLX) announces CMS policy change for radiopharmaceutical reimbursement

    Centers for Medicare & Medicaid Services to ensure consistent reimbursement starting 2025, enhancing patient access

    TLX

    $TLX

    Telix Pharmaceuticals (ASX: $TLX) advances TLX101-CDx for glioma imaging

    FDA accepts NDA for Pixclara, priority review with potential U.S. launch by 2025

    Related Companies
    ANATARA LIFESCIENCES LTD
    $ANR
    PARADIGM BIOPHARMACEUTICALS LIMITED..
    $PAR
    PATRYS LIMITED
    $PAB
    CSL LIMITED
    $CSL
    AVITA MEDICAL INC.
    $AVH

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions